Table of Contents Understanding GSM: What Menopause Actually Does to Intimate Tissues Desire Changes During Menopause: It’s Not Just “Low Libido” Lubricants vs. Moisturizers: Two Different Tools for Two Different Problems Laser and Radiofrequency Treatments: What the Evidence Shows in 2026 Hormone Therapy vs. Non-Hormonal Approaches: A Balanced Comparison Talking to Your Partner About Menopause and Intimacy The Overlooked Role of the Pelvic Floor in Sexual Comfort Lifestyle, Nutrition, and Supplements: What Actually Helps Frequently Asked Questions
- Understanding GSM: What Menopause Actually Does to Intimate Tissues Genitourinary Syndrome of Menopause (GSM) — formerly called vulvovaginal atrophy — is the medical term for the constellation of changes that occur in the vulvar, vaginal, and lower urinary tract tissues when estrogen levels decline. The term was updated in 2014 by the International Society for the Study of Women’s Sexual Health and the North American Menopause Society to better reflect that these changes affect more than just the vagina.
What GSM Affects Vaginal tissue: Becomes thinner, less elastic, and more fragile Natural lubrication: Decreases significantly — both at baseline and during arousal Vaginal pH: Rises from the premenopausal norm of 3.8–4.5 to 5.0 or higher, which alters the microbiome and increases infection risk Vulvar tissue: May thin, lose fat padding, and become more sensitive to friction Urinary tract: Increased urinary urgency, frequency, and UTI susceptibility Pelvic floor: Collagen changes affect muscle and connective tissue support Prevalence: GSM affects an estimated 50–70% of postmenopausal women, yet only about 25% seek treatment, according to the North American Menopause Society (NAMS). Many women do not realize these changes have a name, a cause, and multiple effective treatments — hormonal and non-hormonal alike.
The key thing to understand is that GSM is progressive — it does not get better on its own and tends to worsen over time without intervention. But it is also highly treatable. The goal of treatment is not to “reverse menopause” but to restore comfort, function, and quality of life — including, if you want it, a satisfying intimate life.
- Desire Changes During Menopause: It’s Not Just “Low Libido” The narrative that menopause simply “kills your sex drive” is both inaccurate and unhelpful. The reality is more nuanced — and more hopeful. For many women, desire does not disappear; it transforms. Understanding the difference between spontaneous and responsive desire can be liberating.
Spontaneous vs. Responsive Desire Spontaneous desire: The “out of nowhere” urge — thinking about sex, feeling aroused without direct stimulation. This type of desire is more common in the earlier reproductive years and often declines with age and hormonal changes. Responsive desire: Arousal that emerges after physical intimacy begins — kissing, touch, massage. This type of desire is normal at any age and often becomes the dominant pattern after menopause. Research from Dr. Rosemary Basson at the University of British Columbia has shown that many women in long-term relationships begin sexual activity from a place of emotional intimacy and willingness — not spontaneous hunger — and that this is a healthy, functional pattern, not a disorder.
Pro Tip: If you are waiting to feel spontaneously “in the mood” before initiating intimacy — and that feeling rarely comes — consider experimenting with responsive desire. Agree to 15 minutes of non-goal-oriented touch (massage, cuddling, kissing) without any expectation of where it leads. Many couples find that arousal follows connection, not the other way around.
Other Factors Affecting Desire Pain: If sex hurts, the brain learns to avoid it. Treating the physical causes of discomfort (dryness, tightness) is often the first step to restoring desire. Sleep disruption: Menopause-related insomnia and night sweats are exhausting — and exhaustion is a powerful libido suppressant. Body image: Weight changes, skin changes, and the cultural invisibility of midlife women can affect how desirable a woman feels, which directly impacts desire. Relationship dynamics: Decades-long relationships carry their own complexities. Emotional disconnection, resentment, or unequal household labor can dampen desire more than any hormone shift.
- Lubricants vs. Moisturizers: Two Different Tools for Two Different Problems This distinction is one of the most important things to understand about managing GSM without hormones — and it is one that many women never hear from their healthcare providers.
Feature Lubricants Vaginal Moisturizers Purpose Reduce friction during sexual activity Hydrate vaginal tissue over time, independent of sex When to apply Immediately before or during intimacy Regularly (every 2–3 days), regardless of sexual activity Duration of effect Short-term (hours) Long-term (days) — rehydrates tissue Key ingredients Water, silicone, oil, or hybrid bases Polycarbophil, hyaluronic acid, bioadhesive polymers Best for Immediate comfort during sex Restoring baseline tissue health and elasticity Example products Good Clean Love, Sliquid, Überlube, Yes WB Replens, Gynatrof, Revaree (hyaluronic acid) Clinical guidance: The International Menopause Society and NAMS both recommend regular use of vaginal moisturizers as a first-line intervention for mild-to-moderate GSM, with lubricants used additionally for sexual comfort. A 2023 randomized trial found that hyaluronic acid-based vaginal moisturizers were comparable to low-dose vaginal estrogen for improving vaginal dryness scores over 12 weeks, making them a strong option for women who cannot or prefer not to use hormonal products.
- Laser and Radiofrequency Treatments: What the Evidence Shows in 2026 Energy-based devices — fractional CO₂ laser, erbium YAG laser, and radiofrequency (RF) — have been marketed for GSM treatment for over a decade. They work by delivering controlled thermal energy to vaginal tissue, theoretically stimulating collagen remodeling and improving tissue elasticity, hydration, and thickness. The question has always been: does the evidence match the marketing?
The 2026 Evidence Landscape Treatment Type How It Works Typical Protocol FDA Status (2026) Evidence Strength Fractional CO₂ Laser Micro-ablation triggers healing cascade and collagen production 3 sessions, 4–6 weeks apart; annual maintenance FDA-cleared for gynecologic use (not specifically GSM) Moderate — several RCTs show benefit; long-term safety data still accumulating Erbium YAG Laser Gentler thermal effect; less downtime 3 sessions, 4–6 weeks apart FDA-cleared for gynecologic use Moderate — fewer studies than CO₂ Radiofrequency (RF) Electromagnetic heating of deeper tissue layers 3–5 sessions, weekly or biweekly FDA-cleared for general tissue heating (not GSM-specific) Limited — mostly small, industry-funded studies Important caveats: In 2018, the FDA issued a warning about the use of energy-based devices for “vaginal rejuvenation,” noting that the safety and effectiveness for treating GSM had not been established through rigorous studies. While the evidence base has grown since then, these treatments remain relatively expensive ($800–$1,200 per session in the U.S., typically not covered by insurance) and should be performed by a board-certified gynecologist or urogynecologist — never at a med spa without proper medical oversight.
A 2025 systematic review in Menopause (the journal of NAMS) concluded that while CO₂ laser shows statistically significant improvements in vaginal dryness, dyspareunia, and the Vaginal Health Index compared to sham treatment, the effect sizes are modest, and there is “insufficient evidence to recommend these modalities as first-line therapy.” The review emphasized that vaginal estrogen and non-hormonal moisturizers remain the first-line evidence-based options.
- Hormone Therapy vs. Non-Hormonal Approaches: A Balanced Comparison Many women are understandably cautious about hormone therapy (HT) — whether because of a personal or family history of breast cancer, concerns about side effects, or simply a preference for non-pharmacological approaches. At the same time, low-dose vaginal estrogen is one of the most effective and well-studied treatments for GSM, with minimal systemic absorption. Here is a balanced comparison to help you make an informed decision with your healthcare provider.
Approach What It Is Pros Cons Best For Low-dose vaginal estrogen (cream, ring, tablet) Local estrogen applied directly to vaginal tissue Highly effective; minimal systemic absorption; decades of safety data; reverses tissue thinning Requires prescription; some women have contraindications; ongoing maintenance needed Moderate–severe GSM; women without estrogen-sensitive cancer history Vaginal DHEA (prasterone) Hormone precursor converted locally to estrogen and androgen FDA-approved specifically for dyspareunia due to GSM; effective in clinical trials Prescription only; more expensive than generic estrogen; less long-term data Moderate–severe dyspareunia; may be an option when estrogen is contraindicated (discuss with oncologist) Ospemifene (oral SERM) Selective estrogen receptor modulator taken orally Oral option; FDA-approved for moderate–severe dyspareunia; improves tissue health May increase hot flashes; small VTE risk; prescription only Women who cannot use or prefer not to use vaginal products Vaginal moisturizers (non-hormonal) Over-the-counter hydrating gels/suppositories used regularly No prescription needed; no hormonal effects; good safety profile; accessible Less effective than estrogen for severe GSM; requires consistent use Mild–moderate GSM; women who prefer non-hormonal; adjunct to other treatments Lubricants (non-hormonal) Used during sex to reduce friction Immediate relief; widely available; inexpensive Does not treat underlying tissue changes; must reapply Every woman who experiences dryness during sex, regardless of other treatments Energy-based devices (laser/RF) In-office thermal treatments Non-hormonal; may stimulate collagen; 3 sessions can last ~12 months Expensive; limited long-term data; not first-line; may require maintenance Women who cannot use hormones and haven’t responded to moisturizers Key takeaway: The safest and most effective approach is often layered. A woman might use a vaginal moisturizer every 2–3 days for baseline tissue health, a high-quality lubricant during sex for immediate comfort, and — if symptoms are moderate to severe and she is a candidate — low-dose vaginal estrogen prescribed by her doctor. There is no single “right answer” — only what works for your body, your preferences, and your medical history.
- Talking to Your Partner About Menopause and Intimacy For many women, the hardest part of menopause-related intimacy changes is not the physical symptoms — it is talking about them. If you have been with your partner for decades, sex may have followed a comfortable, unspoken script. When that script no longer works, silence can breed misunderstanding: your partner may interpret your avoidance as rejection, while you may feel ashamed or broken.
A Framework for the Conversation Choose the right time. Not in the bedroom, not in the heat of the moment. A quiet walk, a car ride, or a relaxed evening at home. Lead with “I” statements. “I’ve noticed that sex feels different for me lately — more sensitive, sometimes uncomfortable — and I want us to talk about it because I still want to be close with you.” Educate together. Share that GSM is a medical condition — not a personal failing. Bring your partner to a doctor’s appointment if that feels right. The NAMS website has excellent patient education materials. Redefine intimacy. If penetrative sex is painful, expand the definition of intimacy. Oral sex, manual stimulation, mutual massage, and non-sexual physical affection are all valid and valuable forms of connection. Normalize lubricant. Frame lubricant as a tool for enhanced pleasure for both partners, not as a sign of failure. Many couples find that lubricant makes sex better at any age. Pro Tip: Consider seeing a certified sex therapist or couples counselor who specializes in midlife sexuality. The American Association of Sexuality Educators, Counselors and Therapists (AASECT) maintains a directory of certified professionals. Sometimes a guided conversation with a neutral third party is the most efficient path back to connection.
- The Overlooked Role of the Pelvic Floor in Sexual Comfort Menopause affects the pelvic floor in two directions. Declining estrogen and collagen can lead to weakness and reduced support, contributing to prolapse and stress incontinence. But for many women, the bigger issue is hypertonicity — a pelvic floor that is chronically tight and unable to relax. This can develop as a guarding response to painful intercourse: the body braces against anticipated pain, which makes penetration more painful, which reinforces the guarding. It is a vicious cycle.
A pelvic floor physical therapist can assess whether your pelvic floor is weak, tight, or both, and prescribe appropriate exercises. For many menopausal women with GSM-related dyspareunia, the answer involves down-training (learning to relax the pelvic floor) rather than Kegels.
Pelvic floor physical therapy, when combined with vaginal moisturizers and lubricants, is one of the most effective non-hormonal strategies for restoring comfortable intimacy. Medicare and many private insurers cover pelvic floor PT when medically indicated.
-
Lifestyle, Nutrition, and Supplements: What Actually Helps Evidence-Based Supportive Strategies Intervention What the Evidence Says Recommendation Regular sexual activity (including solo) Increases vaginal blood flow and helps maintain tissue elasticity; “use it or lose it” has some physiological basis Any form of arousal and orgasm — partnered or solo — is beneficial for tissue health Pelvic floor PT Strong evidence for improving dyspareunia and pelvic floor relaxation; recommended by ACOG and NAMS First-line for pelvic floor-related pain Vitamin E suppositories Small studies suggest benefit for vaginal dryness; antioxidant properties may support tissue health Consider as an adjunct; limited but promising data Sea buckthorn oil (oral) Some evidence for improving vaginal dryness; rich in omega-7 fatty acids that support mucous membranes Moderate evidence; discuss with your doctor Soy isoflavones / phytoestrogens Mixed results; modest effect on hot flashes in some studies; limited data for vaginal symptoms May help systemic symptoms; insufficient evidence for GSM alone Adequate hydration Systemic hydration supports all mucous membrane function Simple, free, universally recommended Caution: The supplement industry is poorly regulated. Many products marketed for “menopause relief” or “female libido” contain undisclosed ingredients or make unsubstantiated claims. Always consult your healthcare provider before starting any supplement, especially if you take prescription medications or have a history of hormone-sensitive cancer.
-
Frequently Asked Questions Q: Can I use vaginal estrogen if I have a history of breast cancer?
This is a nuanced decision that must be made with your oncologist. Low-dose vaginal estrogen results in minimal systemic absorption — serum estradiol levels typically remain within the postmenopausal range. However, many oncologists remain cautious, particularly for women on aromatase inhibitors, where even small increases in circulating estrogen are a concern. Non-hormonal options (moisturizers, lubricants, pelvic floor PT, and — with caution — laser/RF) are the safest first-line approaches in this population.
Q: How do I know if I have GSM vs. a yeast infection or something else?
GSM typically presents with gradual onset of dryness, irritation, burning, and dyspareunia — without the thick discharge or intense itching characteristic of yeast infections. The vaginal pH in GSM is elevated (above 5.0), whereas premenopausal vaginal pH is acidic (3.8–4.5). A simple in-office pH test and examination by your gynecologist can usually distinguish GSM from infection. Do not self-diagnose — recurrent symptoms deserve a proper evaluation.
Q: Does menopause mean the end of orgasm?
No. While some women report that orgasms feel different — possibly less intense or requiring more stimulation — the majority of women retain the capacity for orgasm throughout life. The clitoris, unlike the vagina, is not estrogen-dependent for its primary function. Some women actually report improved orgasms after menopause, freed from concerns about pregnancy and with greater self-knowledge about what they need. If you are struggling, a sex therapist or pelvic floor PT can help.
Q: Are over-the-counter “vaginal rejuvenation” creams safe?
Be very skeptical. The FDA has issued multiple warning letters to companies making unsubstantiated claims about over-the-counter products for “vaginal rejuvenation.” These products are not regulated as drugs and have not been proven safe or effective for treating GSM. Stick with evidence-based options: FDA-cleared vaginal moisturizers, lubricants with safe osmolality and pH, and treatments recommended by your healthcare provider.
Q: I’ve lost all interest in sex. Is that just menopause, or could something else be going on?
While hormonal changes contribute to desire shifts, it is important to rule out other causes: thyroid disorders, iron deficiency, depression, certain medications (especially SSRIs), sleep deprivation, chronic stress, and relationship issues can all suppress libido independently of menopause. A thorough evaluation by your primary care provider or a menopause specialist — including blood work and a detailed history — is the best starting point.
Q: How long do I need to use vaginal moisturizers before I notice a difference?
Most women notice some improvement within 2–4 weeks of consistent use (every 2–3 days), with maximum benefit at 8–12 weeks. Unlike lubricants, which work immediately, moisturizers need time to rehydrate the tissue. Consistency matters — using a moisturizer once and then forgetting about it for two weeks will not produce results.
